NIH-funded research NIH-funded research

Preparing for blood-based Alzheimer’s biomarker testing: a decision-support tool for diverse primary care patients

Official title: Preparing for Blood-Based Alzheimer’s Disease Biomarker Testing in Diverse Populations: Development of a Decision-Support Tool for Primary Care

Funded at University of Wisconsin-Madison · NIH-11385571 · Data updated 2026-11-12

A doctor-scientist is being trained to create an easy, patient-friendly tool to help diverse people decide about blood tests that detect Alzheimer’s risks.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$248,489
NIH project number5R00AG083131-04
Project IDNIH-11385571 on NIH RePORTER

Who could benefit from this research

Could help

Adults at risk for Alzheimer’s disease or related dementias who receive care in primary settings and represent diverse racial/ethnic backgrounds.

Less likely to help

Patients not considering biomarker testing or those outside primary care or diversity-focused settings may not directly benefit.

What this research studies

This grant supports training an early-career clinician-scientist to develop interventions that help diverse patients understand and make decisions about blood biomarker testing for Alzheimer’s risk in primary care. The project combines qualitative research, user-centered design, and behavioral intervention methods within healthcare settings. The aim is to pilot a decision-support tool that improves communication and decision-making around preclinical biomarker testing, with a focus on inclusivity for racially and ethnically diverse populations. The work will culminate in a pilot study within real primary care environments to test feasibility and acceptability.

Why it matters

Potential benefit: If successful, patients will have clearer information and support to make timely, informed choices about biomarker testing for Alzheimer’s risk.

How similar studies have gone: Previous work shows that well-designed decision-support tools can improve patient understanding and shared decision-making in similar contexts, though this specific approach for AD biomarker testing is novel.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Ketchum, Fred — University of Wisconsin-Madison
  • Study coordinator: Ketchum, Fred

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.